Brain overgrowth dictates autism severity, new research suggests
New research linking prenatal brain overgrowth to autism severity prompts both excitement and skepticism, with some praising the organoid-based findings while others question the tiny sample size and leap from lab model to human development. Commenters debate whether autism and related neurodivergences are primarily disabling pathologies to be prevented or treated, or adaptive variations that can benefit individuals and societies given the right support. Ethical tensions surface around ideas like prenatal testing, abortion, and “curing” autism, especially in light of stark differences between mildly and profoundly autistic people and the historical harms of eugenic thinking and coercive therapies.
Biological findings & mechanisms
- Several commenters note prior work linking autism to early brain overgrowth, excess neurons, and too many synaptic connections; this new organoid work is seen as consistent with that.
- Others stress that overgrowth is a normal fetal process followed by pruning; the issue may be dysregulated growth/pruning, not “too much brain” per se.
- Autism is often framed as a sensory‑processing and connectivity issue (too much incoming stimulus, hyper‑responsivity), not “pressure in the skull” like a tumor.
- Macrocephaly and larger brain mass are mentioned as more common in autistic people, but not universal.
Research methods, sample size, and limits
- Multiple comments criticize tiny sample sizes (single‑digit ASD and control toddlers) and the difficulty of generalizing from organoids to actual fetal brains.
- A researcher involved in related work explains how laborious iPSC/organoid and MRI studies are, and that small N is common but can still show large effects.
- Others highlight sampling bias in autism neuroimaging (severe and intellectually disabled autistics are underrepresented) and note longitudinal data that do not show simple “overgrowth then regression”.
- Some argue media coverage overstates what’s “established,” given organoids are only proxies.
Autism: disease, disorder, or diversity?
- Strong divide between viewing autism as:
- A neurodevelopmental disorder with often severe, debilitating consequences; or
- A form of neurodiversity that can be adaptive or valuable at population level.
- Some autistic commenters say they would not choose to be “cured” and see clear upsides (hyperfocus, systems thinking, strong ethics), provided environments accommodate them.
- Parents of severely autistic, non‑verbal children emphasize intense suffering, lifelong dependence, and reject “autism as superpower” narratives as erasing these realities.
Severity spectrum and terminology
- Debate over “mild vs profound autism”, “high functioning”, and historical labels like Asperger’s:
- Some find finer-grained labels useful to distinguish relatively independent autistic adults from those needing 24/7 care.
- Others argue autism is highly heterogeneous; simple subtypes or functioning labels fail and can be ableist.
Treatment, support, and ethics
- Tension between:
- Developing interventions (potentially even in utero) to reduce severe impairment, and
- Fears of eugenics (selective abortion, “eradicating” autistic people).
- Many stress improving supports: therapy focused on life skills and communication, sensory accommodations, caregiver assistance, rather than trying to “normalize” personality.
- There is sharp criticism of older or coercive therapies (e.g., some ABA practices) versus more respectful, child‑centered approaches.
ADHD and broader neurodivergence
- Frequent parallels drawn to ADHD: some see evolutionary or niche advantages; others emphasize that unmedicated life can be catastrophic.
- Strong pushback against romanticizing pathology: traits can have context‑dependent benefits, but many individuals still need and want medical and practical support.